Intravesical injection of onabotulinumtoxinA in neurogenic overactive bladder patients with human T‐cell leukemia virus type 1‐associated myelopathy: A single‐institution case series

MLA

Tatsufumi Nakamura, et al. “Intravesical Injection of OnabotulinumtoxinA in Neurogenic Overactive Bladder Patients with Human T‐cell Leukemia Virus Type 1‐associated Myelopathy: A Single‐institution Case Series.” IJU Case Reports, vol. 4, no. 4, July 2021, pp. 251–54. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a56d15d60cb6ac83450e75552726a91d&authtype=sso&custid=ns315887.

APA

Tatsufumi Nakamura, Katsuya Sato, Yasuyoshi Miyata, Tomohiro Matsuo, & Hideki Sakai. (2021). Intravesical injection of onabotulinumtoxinA in neurogenic overactive bladder patients with human T‐cell leukemia virus type 1‐associated myelopathy: A single‐institution case series. IJU Case Reports, 4(4), 251–254.

Chicago

Tatsufumi Nakamura, Katsuya Sato, Yasuyoshi Miyata, Tomohiro Matsuo, and Hideki Sakai. 2021. “Intravesical Injection of OnabotulinumtoxinA in Neurogenic Overactive Bladder Patients with Human T‐cell Leukemia Virus Type 1‐associated Myelopathy: A Single‐institution Case Series.” IJU Case Reports 4 (4): 251–54. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a56d15d60cb6ac83450e75552726a91d&authtype=sso&custid=ns315887.